| Oct 30 |
AbbVie: 3 Positives From The Earnings Report
|
| Oct 30 |
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
|
| Oct 30 |
AbbVie Inc. (ABBV) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
What’s behind AbbVie's Q3 revenue beat?
|
| Oct 30 |
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
AbbVie Trumps Q3 Earnings & Sales Estimates, Raises '24 EPS View
|
| Oct 30 |
Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key Metrics
|
| Oct 30 |
AbbVie Raises Full-Year Outlook Following Third-Quarter Beat
|
| Oct 30 |
AbbVie Stock Rises After Earnings Beat, Dividend Hike
|
| Oct 30 |
AbbVie (ABBV) Surpasses Q3 Earnings and Revenue Estimates
|
